Latest Insider Transactions at Paratek Pharmaceuticals, Inc. (PRTK)
This section provides a real-time view of insider transactions for Paratek Pharmaceuticals, Inc. (PRTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Paratek Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Paratek Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2022
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
19,484
-1.58%
|
$19,484
$1.98 P/Share
|
|
Dec 12
2022
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
11,105
-3.14%
|
$11,105
$1.98 P/Share
|
|
Dec 12
2022
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
14,410
-3.29%
|
$14,410
$1.98 P/Share
|
|
Dec 12
2022
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
37,831
-2.96%
|
$37,831
$1.98 P/Share
|
|
Dec 12
2022
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
3,820
-0.59%
|
$3,820
$1.98 P/Share
|
|
Oct 28
2022
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
4,563
-0.7%
|
$13,689
$3.47 P/Share
|
|
Oct 28
2022
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
6,000
-0.48%
|
$18,000
$3.47 P/Share
|
|
Oct 28
2022
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
3,516
-0.98%
|
$10,548
$3.47 P/Share
|
|
Oct 28
2022
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
4,382
-0.99%
|
$13,146
$3.47 P/Share
|
|
Oct 28
2022
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
8,805
-0.68%
|
$26,415
$3.47 P/Share
|
|
Oct 25
2022
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+2.37%
|
-
|
|
Oct 25
2022
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
8,500
+2.32%
|
-
|
|
Oct 25
2022
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
9,250
+2.05%
|
-
|
|
Oct 25
2022
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+2.28%
|
-
|
|
Oct 25
2022
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+2.26%
|
-
|
|
Aug 09
2022
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
44,519
-3.42%
|
$89,038
$2.66 P/Share
|
|
Aug 09
2022
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
22,453
-4.93%
|
$44,906
$2.66 P/Share
|
|
Aug 09
2022
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
19,608
-5.32%
|
$39,216
$2.66 P/Share
|
|
Aug 09
2022
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
28,637
-2.32%
|
$57,274
$2.66 P/Share
|
|
Aug 08
2022
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
71,591
+10.13%
|
-
|
|
Aug 08
2022
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
152,727
+10.5%
|
-
|
|
Aug 08
2022
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
47,727
+9.49%
|
-
|
|
Aug 08
2022
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
47,727
+11.46%
|
-
|
|
Aug 08
2022
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
143,182
+10.38%
|
-
|
|
Mar 15
2022
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
202,500
+15.63%
|
-
|
|
Mar 15
2022
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
67,500
+17.37%
|
-
|
|
Mar 15
2022
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
67,500
+14.21%
|
-
|
|
Mar 15
2022
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
236,250
+17.05%
|
-
|
|
Mar 15
2022
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
101,250
+15.23%
|
-
|
|
Feb 16
2022
|
Minnie Baylor Henry Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+33.78%
|
-
|
|
Feb 16
2022
|
Thomas John Dietz Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+28.57%
|
-
|
|
Feb 16
2022
|
Timothy R Franson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+25.32%
|
-
|
|
Feb 16
2022
|
Rolf K Hoffmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+23.81%
|
-
|
|
Feb 16
2022
|
Kristine Peterson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+25.32%
|
-
|
|
Feb 16
2022
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+27.68%
|
-
|
|
Feb 16
2022
|
Jeffrey Stein Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+26.45%
|
-
|
|
Dec 15
2021
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
22,624
-4.67%
|
$90,496
$4.27 P/Share
|
|
Dec 15
2021
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
49,259
-5.12%
|
$197,036
$4.27 P/Share
|
|
Dec 15
2021
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
17,178
-4.81%
|
$68,712
$4.27 P/Share
|
|
Dec 15
2021
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
15,780
-5.86%
|
$63,120
$4.27 P/Share
|
|
Dec 15
2021
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
17,819
-1.96%
|
$71,276
$4.27 P/Share
|
|
Dec 14
2021
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
10,946
-2.21%
|
$43,784
$4.37 P/Share
|
|
Dec 14
2021
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
23,834
-2.42%
|
$95,336
$4.37 P/Share
|
|
Dec 14
2021
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
8,312
-2.27%
|
$33,248
$4.37 P/Share
|
|
Dec 14
2021
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
7,635
-2.76%
|
$30,540
$4.37 P/Share
|
|
Dec 14
2021
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
8,622
-0.94%
|
$34,488
$4.37 P/Share
|
|
Dec 13
2021
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
6,422
-1.28%
|
$25,688
$4.42 P/Share
|
|
Dec 13
2021
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
13,983
-1.4%
|
$55,932
$4.42 P/Share
|
|
Dec 13
2021
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
4,876
-1.32%
|
$19,504
$4.42 P/Share
|
|
Dec 13
2021
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
4,479
-1.59%
|
$17,916
$4.42 P/Share
|